INVESTORS
Investor Contact
Private-to-Public Company Pathway to Initial Public Offering
Zephyr Labz’s strategic consolidation and growth strategy, in alignment with emerging high growth markets in nutraceutical, cosmeceutical and pharmaceutical, will help to accelerate shareholder values and provide higher opportunity as we move toward other significant events such as further accretive M&A opportunities and Company IPO in the near term.
The Company is filing an Initial Public Offering upon completion of its current phase of acquisitions. As a public company, Zephyr Labz will be able to attract a larger audience of potential customers and investors as it positions itself as a leading international bioscience and nutraceutical products company creating innovative products and delivery technologies.
